Isogenica
Isogenica is a drug discovery platform-licensing company focusing on the design and build of diverse, fully synthetic, antibody libraries for use in biopharmaceutical discovery. Partners can access an advanced camelid single-domain antibody library (llamdA™) and state-of-the-art, fully synthetic and highly diverse human Fab antibody libraries (Alexandria™). The company uses its proprietary Colibra™ library technology to ensure that the libraries very accurately reflect its advanced designs. Libraries can be screened in various formats, including phage and CIS Display, a proprietary in vitro display technology which maintains the high diversity of the llamdA™ libraries through the discovery process. CIS Display is also available as a stand-alone polypeptide display technology.
About Isogenica
Founded
2001Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$9MCategory
Sector
Commercial Physical and Biological ResearchIndustry Group
Research, Development, and Testing ServicesIndustry
BiotechnologyLocation
City
Little ChesterfordState
EssexCountry
United KingdomIsogenica
Find your buyer within Isogenica